Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 14(7): e0220211, 2019.
Article in English | MEDLINE | ID: mdl-31339938

ABSTRACT

Spinal Muscular Atrophy (SMA) is a disorder characterized by the degeneration of motor neurons in the spinal cord, leading to muscular atrophy. In the majority of cases, SMA is caused by the homozygous absence of the SMN1 gene. The disease severity of SMA is strongly influenced by the copy number of the closely related SMN2 gene. In addition, an SMN variant lacking exons 7 and 8 has been reported in 8% and 23% of healthy Swedish and Spanish individuals respectively. We tested 1255 samples from the 1000 Genomes Project using a new version of the multiplex ligation-dependent probe amplification (MLPA) P021 probemix that covers each SMN exon. The SMN variant lacking exons 7 and 8 was present in up to 20% of individuals in several Caucasian populations, while being almost completely absent in various Asian and African populations. This SMN1/2Δ7-8 variant appears to be derived from an ancient deletion event as the deletion size is identical in 99% of samples tested. The average total copy number of SMN1, SMN2 and the SMN1/2Δ7-8 variant combined was remarkably comparable in all populations tested, ranging from 3.64 in Asian to 3.75 in African samples.


Subject(s)
Muscular Atrophy, Spinal/epidemiology , Muscular Atrophy, Spinal/genetics , Survival of Motor Neuron 1 Protein/genetics , Cells, Cultured , DNA Copy Number Variations , Ethnicity/genetics , Ethnicity/statistics & numerical data , Exons/genetics , Female , Gene Frequency , Genetics, Population , Geography , Humans , Male , Polymorphism, Genetic , Sequence Deletion , Survival of Motor Neuron 2 Protein/genetics
2.
Genet Test Mol Biomarkers ; 20(3): 158-61, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26798991

ABSTRACT

BACKGROUND: Genotyping of HLA-DQ2.2, HLA-DQ2.5, and HLA-DQ8 is important in celiac disease (CD). The absence of these three genotypes has a strong negative predictive value. METHODS: We designed multiplex ligation-dependent probe amplification (MLPA) for the combined detection of HLA-DQ2.2, HLA-DQ2.5, and HLA-DQ8. The MLPA probe mix was validated against a set of 59 samples characterized by conventional techniques. RESULTS: The MLPA assay genotyped all 59 samples correctly when compared to the results obtained by PCR-SSCP/HD or PCR-SSO and PCR-SSP. CONCLUSION: The MLPA assay provides a reliable single-reaction analysis of the CD risk genotypes HLA-DQ2.2, HLA-DQ2.5, and HLA-DQ8 allowing for stratification or exclusion of disease risk.


Subject(s)
Celiac Disease/genetics , HLA-DQ Antigens/genetics , Alleles , Celiac Disease/blood , Gene Frequency/genetics , Genetic Predisposition to Disease , Genotype , HLA-DQ Antigens/blood , Haplotypes , Humans , Multiplex Polymerase Chain Reaction/methods , Risk Factors
3.
Clin Chem Lab Med ; 51(6): 1191-8, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23314539

ABSTRACT

BACKGROUND: Celiac disease (CD) is an inflammatory disorder of the small intestine induced by gluten ingestion. CD has a strong genetic association with human leukocyte antigen (HLA)-DQ2.5 and HLA-DQ8. The absence of HLA-DQ2.5 and HLA-DQ8 has a strong negative predictive value for CD. Genetic screening of HLA-DQ2.5 and HLA-DQ8 in patients at risk is of great value. METHODS: We designed, developed, and validated a multiplex assay based on multiplex ligation-dependent probe amplification (MLPA) technology, allowing the simultaneous detection of DQA1*05-DQB1*02, encoding HLA-DQ2.5, and DQA1*03-DQB1*03:02, encoding HLA-DQ8. The amplified products were separated and identified using capillary electrophoresis. RESULTS: When compared with a polymerase chain reaction followed by single-strand conformation polymorphism/ heteroduplex analysis, one discrepancy was found. Sequencing analysis showed that the developed MLPA assay result was correct. Furthermore, we demonstrated that the MLPA method is able to distinguish between the heterozygote and homozygote expression of HLA-DQ2.5 or HLA-DQ8. CONCLUSIONS: This study shows that it is possible to rapidly and accurately screen for the absence of HLA-DQ2.5 and HLA-DQ8 using MLPA, excluding patients at risk for CD for further serological or histological follow-up. In addition, MLPA might be an accurate tool to screen for other specific HLA types in the context of disease association in a diagnostic laboratory setting.


Subject(s)
Celiac Disease/diagnosis , Celiac Disease/immunology , HLA-DQ Antigens/analysis , HLA-DQ Antigens/biosynthesis , Multiplex Polymerase Chain Reaction/methods , Celiac Disease/genetics , Electrophoresis, Capillary/methods , Genetic Predisposition to Disease , HLA-DQ Antigens/genetics , Humans , Polymerase Chain Reaction/methods , Polymorphism, Single-Stranded Conformational , Risk Factors , Sequence Analysis, DNA
SELECTION OF CITATIONS
SEARCH DETAIL
...